Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Muna Therapeutics Launches with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for neurodegenerative diseases, today […]
AI Software Which Helps Diagnose Lung Cancer Receives Gov Funding Boost
New AI software to help better diagnose lung cancer has received major government funding. Lung […]
Olive Hits a $4 Billion Valuation with $400 Million of Capital Led by Vista Equity Partners
Olive, the automation company creating the Internet of Healthcare, announced today it closed a $400 million funding […]
Doctrin Raises €13 Million to Accelerate International Expansion
Swedish health tech company Doctrin raises €13 million to fuel further expansion. The round is led by […]
SHINE Medical Technologies Closes $150-million Series C-5 Financing to Advance Nuclear Fusion-Based Technologies
SHINE Medical Technologies LLC today announced that it has closed a $150-million Series C-5 financing. […]
CMR Surgical Raises $600 Million in Series D Financing
CMR Surgical (CMR or “the Company”), a global surgical robotics business, today announces that it […]
Vida Ventures Closes $825 Million Vida III Fund to Advance Transformative Biomedical Innovations
Vida Ventures (“Vida”), a next-generation life sciences venture firm, announced today the closing of Vida Ventures […]
Gliknik Inc. Raises $11.5 Million in Series C Financing
Gliknik Inc., an immunology company dedicated to patients with cancer and autoimmune disorders, today announced […]
£64 Million Funding to Back UK-wide Plan to Strengthen Clinical Research Delivery
Better health outcomes through more effective and efficient research as seen throughout the pandemic Promoting […]
NuvoAir Raises $12M in Series A Funding to Improve the Care of Millions Suffering From Lung Conditions
NuvoAir – the digital health company on a mission to improve the lives of millions […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more